Testimony: FDA Commissioner says FDA has limited authority over compounding pharmacies to prevent meningitis outbreak

Article

During a four-hour hearing Nov. 14 led by the chairman of the House Energy and Commerce oversight subcommittee, FDA Commissioner Margaret Hamburg was asked if the FDA could have prevented the recent fungal meningitis outbreak.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.